Moderna stock rises on positive results in flu vaccine trial

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Moderna (MRNA) shares are ticking up this morning after the pharmaceutical company published positive data from its latest flu vaccine trial. Yahoo Finance Health Care Reporter Anjalee Khemlani outlines Moderna's new post-COVID strategy to expand personalized care, quoting CFO James Mock's plans to prepare new COVID, RSV, and flu vaccines this season.

You'll be surprised to learn that Dubai has these ten things...STORY: Anirudh's parents try to feed him in hospital about a week before he died of kidney injury in January 2020. The two-year-old had taken toxic cough syrup, his parents said. He is among at least 12 infants in Jammu and Kashmir poisoned by such syrups, according to Indian police, who point to one Indian manufacturer - Digital Vision Pharma.Reuters spoke to the families of six of the dead children.

”“We miss him every day,” she says. Anirudh also took ColdBest, then rapidly deteriorated.A district court in Jammu and Kashmir is hearing the criminal case against Digital Vision’s founder, Parshottam Goyal, and his two sons.They deny any wrongdoing.Another court previously barred Digital Vision from making certain cough syrups, but it is making other drugs. Parshottam Goyal told Reuters it has tripled its production capacity.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines